Anxiety symptoms and risk factors in patients with SARS-cov-2 omicron variant in shanghai, China.
Qing ChenYong ChenYi HuangQinglin YangDe-Ying HeBang-Jiang FangYi RenJun LiuPublished in: International journal of psychiatry in medicine (2024)
Alleviation of respiratory symptoms, addressing comorbidities, and both psychological and psychopharmacological treatments may help reduce anxiety symptoms following infection with the SARS-CoV-2 omicron variant in mainland China.